Previous 10 | Next 10 |
BOSTON, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Covant Therapeutics, an innovative covalent drug discovery company, is pleased to announce the appointment of Vincent Hennemand as Chief Executive Officer (CEO). Vincent Hennemand is a seasoned executive with a distinguished career in the pharmaceutic...
2023-10-09 13:48:11 ET The FDA's decision to reject a label expansion for Alnylam’s ( NASDAQ: ALNY ) amyloidosis therapy patisiran on Monday pressured shares of Arbutus Biopharma ( NASDAQ: ABUS ), which has out-licensed the product to the RNAi therapeutics company. ...
2023-10-03 12:23:17 ET More on Roivant Sciences Skin In The Game: Behind Roivant's Significant Rise Roivant Sciences Ltd. (ROIV) Q1 2023 Earnings Call Transcript Roivant Sciences Ltd. 2023 Q1 - Results - Earnings Call Presentation Immunovant to raise $450M fr...
2023-10-01 08:30:00 ET Despite the infamous market crashes in October of 1907, 1929, and 1987, October is actually one of the better months for stocks from a historical perspective. In fact, stocks tend to perk up at the start of the fourth quarter, making it one of the better-performing pe...
2023-09-29 17:45:26 ET More on Roivant Sciences Skin In The Game: Behind Roivant's Significant Rise Roivant Sciences Ltd. (ROIV) Q1 2023 Earnings Call Transcript Roivant Sciences Ltd. 2023 Q1 - Results - Earnings Call Presentation Immunovant to raise $450M fr...
2023-09-28 07:31:31 ET More on Immunovant, Roivant, etc. Immunovant: Immune Boost, From Clinical Trials To An Aggressive Bullish Stock Immunovant: Data Sizzles, But The Steak Isn't Done Yet (Rating Upgrade) Skin In The Game: Behind Roivant's Significant Rise ...
2023-09-27 12:21:54 ET Shares of Immunovant (NASDAQ: IMVT) , an autoimmune specialist and subsidiary of Roivant Sciences (NASDAQ: ROIV) , are showing no signs of cooling off after nearly doubling in value on Tuesday. Specifically, the drugmaker's shares were up by another 5....
2023-09-27 10:29:47 ET More on Immunovant Immunovant: Immune Boost, From Clinical Trials To An Aggressive Bullish Stock Immunovant: Data Sizzles, But The Steak Isn't Done Yet (Rating Upgrade) Immunovant, Inc. 2023 Q2 - Results - Earnings Call Presentation Imm...
2023-09-27 09:55:35 ET DENVER, Colo., Sept 27, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ShiftPixy Inc (NASDAQ: PIXY), Galecto Inc (NASDAQ: GLTO), Cardiff Oncology Inc (NASDAQ: CRDF), American Strat...
2023-09-26 22:12:00 ET Roivant Sciences ( NASDAQ: ROIV ) stock price surged on Tuesday as investors cheered the latest developments with Immunovant (NASDAQ: IMVT). The shares jumped by more than 20% and retested the year-to-date high of $12.90. They have soared by more than 390% fro...
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Ltd. Website:
2024-06-02 17:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...
BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 30, 2024, to report its financial results for the fourth quarter and fiscal year ended March 31...